Welcome to LookChem.com Sign In|Join Free
  • or
2-(phenylamino)pyrimidine-4-carboxylic acid is a pyrimidine derivative with the molecular formula C10H8N4O2. It features a carboxylic acid functional group and a phenylamino substituent, making it a promising chemical compound for pharmaceutical research and drug development.

1360802-78-3

Post Buying Request

1360802-78-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1360802-78-3 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
2-(phenylamino)pyrimidine-4-carboxylic acid is used as a building block for the synthesis of new bioactive molecules. Its unique structure and properties make it of interest to chemists and researchers studying organic and medicinal chemistry.
Used in Organic Chemistry:
2-(phenylamino)pyrimidine-4-carboxylic acid is used as a key intermediate in the synthesis of various organic compounds, contributing to the development of novel chemical entities with potential applications in various fields.
Used in Medicinal Chemistry:
2-(phenylamino)pyrimidine-4-carboxylic acid is used as a starting material for the design and synthesis of new drugs, targeting specific biological pathways and mechanisms of action. Its versatile structure allows for the development of compounds with improved pharmacological properties and therapeutic potential.

Check Digit Verification of cas no

The CAS Registry Mumber 1360802-78-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,0,8,0 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1360802-78:
(9*1)+(8*3)+(7*6)+(6*0)+(5*8)+(4*0)+(3*2)+(2*7)+(1*8)=143
143 % 10 = 3
So 1360802-78-3 is a valid CAS Registry Number.

1360802-78-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-anilinopyrimidine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-(phenylamino)pyrimidine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1360802-78-3 SDS

1360802-78-3Downstream Products

1360802-78-3Relevant academic research and scientific papers

CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins

Bard, Jonathan A.,Brown, Christopher J.,Chen, Xuemei,Clark-Frew, Daniel,Coe, Samuel,Conlon, Mike,Davis, Randall,Dominguez, Celia,Ensor, Samantha,Esposito, Simone,Gai, Xinjie,Green, Samantha,Greenaway, Catherine,Haber, James,Halldin, Christer,Hayes, Sarah,He?mann, Manuela,Herbst, Todd,Herrmann, Frank,Hsai, Ming Min,Johnson, Peter D.,Khetarpal, Vinod,Kotey, Adrian,Lee, Matthew R.,Liu, Longbin,Mangette, John E.,Mills, Matthew R.,Monteagudo, Edith,Moren, Anton Forsberg,Mrzljak, Ladislav,Munoz-Sanjuan, Ignacio,Nag, Sangram,Nibbio, Martina,Orsatti, Laura,Prime, Michael E.,Schaertl, Sabine,Scheich, Christoph,Sproston, Joanne,Stepanov, Vladimir,Varn?s, Katarina,Varrone, Andrea,Wityak, John

, p. 12003 - 12021 (2021/09/02)

The expanded polyglutamine-containing mutant huntingtin (mHTT) protein is implicated in neuronal degeneration of medium spiny neurons in Huntington's disease (HD) for which multiple therapeutic approaches are currently being evaluated to eliminate or redu

HETEROCYCLIC COMPOUND

-

Paragraph 0336, (2016/09/26)

The problem of the present invention is to provide a compound having a PDE2A inhibitory action, and useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

SUBSTITUTED AMIDE DERIVATIVES AS DGAT-1 INHIBITORS

-

Page/Page column 70-71, (2012/03/11)

Described herein are compounds of formula I. The compounds of formula I act as DGAT-1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1360802-78-3